Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Immunophenotype and Response to Immunotherapy of RET-Rearranged Lung Cancers.

Michael Offin | Robin Guo | Stephanie L Wu | Joshua Sabari | Josiah D Land | Ai Ni | Joseph Montecalvo | Darragh F Halpenny | Larry W Buie | Terry Pak | Dazhi Liu | Gregory J Riely | Matthew D Hellmann | Ryma Benayed | Maria Arcila | Mark G Kris | Charles M Rudin | Bob T Li | Marc Ladanyi | Natasha Rekhtman | Alexander Drilon
JCO precision oncology | 2019

No abstract available

Pubmed ID: 31192313

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: P30 CA008748
  • Agency: NCI NIH HHS, United States
    Id: R25 CA020449
  • Agency: NCI NIH HHS, United States
    Id: T32 CA009207

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Cell Signaling Technology (tool)

RRID:SCR_004431

Privately held company that develops and produces antibodies, ELISA kits, ChIP kits, proteomic kits, and other related reagents used to study cell signaling pathways that impact human health.

View all literature mentions